18 March 2025 in Journal of the Society for Cardiovascular Angiography & Interventions
14 January 2025 in Journal of the Society for Cardiovascular Angiography & Interventions
27 January 2022 in Journal of Transcatheter Interventions
Invasive physiological assessment of the coronary circulation has emerged in recent years as a valuable diagnostic approach in the management of patients with chronic coronary syndrome, overcoming important limitations such as evaluating function from the anatomy and the low spatial resolution associated with angiography or non-invasive tests. The value of hyperemic flow measurements to estimate the functional relevance of coronary stenoses is supported by many studies. The aim of this paper is to review the physiological bases, clinical applications and limitations of myocardial fractional flow reserve, the main index used in the invasive functional assessment of the coronary circulation.
4 August 2026 in ABC Imagem Cardiovascular
Introdução As anomalias coronárias congênitas constituem um grupo heterogêneo de variações anatômicas, geralmente identificadas de forma incidental
3 September 2026 in ABC Imagem Cardiovascular
Introduction Congenital coronary anomalies comprise a heterogeneous group of anatomical variations, most often identified incidentally during non-invasive
31 July 2025 in Journal of the Society for Cardiovascular Angiography & Interventions
CRChristopher A. Rajkumar
+8
Coronary microvascular function assessment with invasive Doppler-derived coronary flow reserve (CFR) has challenges related to Doppler signal quality, limiting clinical adoption. We investigated whether the use of ultrasound microbubble contrast agents can improve coronary flow signals and reduce measurement variability during invasive CFR measurement. Participants underwent assessment of coronary flow velocity using a Doppler sensor-tipped coronary wire. Baseline signal quality was determined by expert clinicians, and signals were categorized into good or poor quality. Doppler quality was then assessed at predetermined time periods after administration of SonoVue (Bracco): baseline, first pass, and subsequent discrete 20-second time periods, following this up to 260 seconds after first pass. For each time period, several parameters were assessed: signal-to-noise ratio, Doppler envelope quality (analyzed by a previously validated artificial intelligence–based score), and the coefficient of variation of tracked flow velocity. Fifteen cases were included. In the group with poor quality baseline Doppler signal (N = 10), signal-to-noise ratio, Doppler envelope quality score, and coefficient of variation significantly improved with microbubble contrast (signal-to-noise ratio: P < .05 for all periods after first pass; Doppler envelope quality score: P < .05 for all periods; coefficient of variation: P < .05 for all periods). In the group with a good quality baseline Doppler signal (N = 5), there were no changes in these parameters. Microbubble administration did not cause significant coronary hyperemia (P = .875 when compared to baseline). Ultrasound microbubble contrast agents can enhance Doppler signal quality during invasive CFR measurements. These agents could be used to improve the reliability of flow measurements in clinical practice and facilitate the adoption of coronary microvascular assessment.